Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 27/10/22 → 27/07/24 |
Keywords
- Clinical trial
- haematological malignancy
- ATR inhibitor
- Pharmacokinetics
Clinical Trial Phase
- Phase I
A Phase I, Open-Label, Multi-Center, Dose Finding Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of ATG-018 (ATR inhibitor) Treatment in Patients with Advanced Solid Tumors and Hematological Malignancies (ATRIUM)
- Ameratunga, Malaka (Primary Chief Investigator (PCI))
- Brooks, Christine (Project Manager)
Project: Research